skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 235746 Find in a Library
Title: Public Health Preparedness: Developing and Acquiring Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Agents
Author(s): Cynthia A. Bascetta
Date Published: 2011
Page Count: 19
Sponsoring Agency: US Government Accountability Office
Washington, DC 20548
Publication Number: GAO-11-567T
Sale Source: US Government Accountability Office
441 G Street, NW
Washington, DC 20548
United States of America
Document: PDF
Type: Legislative Hearing/Committee Report
Format: Document
Language: English
Country: United States of America
Annotation: This report presents testimony before the Subcommittee on Emergency Preparedness, Response, and Communications, Committee on Homeland Security regarding the activities of the U.S. Department of Health and Human Services in developing and acquiring medical countermeasures against chemical, biological, radiological, and nuclear agents.
Abstract: This testimony indicates that the U.S. Department of Health and Human Services’ (HHS) medical countermeasure acquisition strategy is based on a four-step process: (1) identify and assess the threat of chemical, biological, radiological, and nuclear (CBRN) agents; (2) assess medical and public health consequences of attacks with these agents; (3) establish medical countermeasure requirements; and (4) identify and prioritize near-, mid-, and long-term development and acquisition. Through this process, HHS is able to identify which countermeasures to buy for specific CBRN agents. However, while a few CBRN countermeasures are immediately available most have not yet been developed. The report also details the challenges facing the Federal Government in developing and acquiring medical countermeasures, such as high failure rates in research and development and difficulties meeting regulatory requirements. This report presents testimony from the Government Accountability Office (GAO) regarding HHS’s CBRN medical countermeasure development and acquisition activities. The evaluation by GAO focused on how HHS determines what kinds of CBRN medical countermeasures are needed and their priorities for development and acquisition, as well as challenges faced by HHS in the development and acquisition of medical countermeasures. Figure and appendix
Main Term(s): Domestic Preparedness
Index Term(s): Biological weapons; Chemical Weapons; Domestic terrorism; Nuclear terrorism; Terrorism/Mass Violence; Terrorist weapons; US Department of Health and Human Services
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.